Bluebird Bio Stock Price Prediction

BLUE Stock  USD 0.39  0.03  7.14%   
At the present time, the RSI of Bluebird Bio's share price is approaching 43 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Bluebird Bio, making its price go up or down.

Oversold Vs Overbought

43

 
Oversold
 
Overbought
The successful prediction of Bluebird Bio's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Bluebird Bio and does not consider all of the tangible or intangible factors available from Bluebird Bio's fundamental data. We analyze noise-free headlines and recent hype associated with Bluebird bio, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Bluebird Bio's stock price prediction:
EPS Estimate Next Quarter
(0.22)
EPS Estimate Current Year
(1.40)
EPS Estimate Next Year
(0.74)
Wall Street Target Price
2.3571
EPS Estimate Current Quarter
(0.35)
Using Bluebird Bio hype-based prediction, you can estimate the value of Bluebird bio from the perspective of Bluebird Bio response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Bluebird Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying Bluebird because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Bluebird Bio after-hype prediction price

    
  USD 0.4  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Bluebird Bio Basic Forecasting Models to cross-verify your projections.
For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bluebird Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.102.0717.38
Details
Naive
Forecast
LowNextHigh
0.010.4715.78
Details
10 Analysts
Consensus
LowTargetHigh
6.467.107.88
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.36-0.35-0.33
Details

Bluebird Bio After-Hype Price Prediction Density Analysis

As far as predicting the price of Bluebird Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bluebird Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bluebird Bio, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Bluebird Bio Estimiated After-Hype Price Volatility

In the context of predicting Bluebird Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bluebird Bio's historical news coverage. Bluebird Bio's after-hype downside and upside margins for the prediction period are 0.02 and 15.71, respectively. We have considered Bluebird Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.39
0.40
After-hype Price
15.71
Upside
Bluebird Bio is abnormally volatile at this time. Analysis and calculation of next after-hype price of Bluebird bio is based on 3 months time horizon.

Bluebird Bio Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Bluebird Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bluebird Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bluebird Bio, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.27 
15.33
 0.00  
  0.42 
8 Events / Month
14 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.39
0.40
0.43 
153,300  
Notes

Bluebird Bio Hype Timeline

Bluebird bio is currently traded for 0.39. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.42. Bluebird is anticipated to increase in value after the next headline, with the price projected to jump to 0.4 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 0.43%, whereas the daily expected return is currently at 0.27%. The volatility of related hype on Bluebird Bio is about 981.99%, with the expected price after the next announcement by competition of -0.03. The company reported the previous year's revenue of 29.5 M. Net Loss for the year was (211.91 M) with loss before overhead, payroll, taxes, and interest of (247.24 M). Given the investment horizon of 90 days the next anticipated press release will be in about 8 days.
Check out Bluebird Bio Basic Forecasting Models to cross-verify your projections.
For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.

Bluebird Bio Related Hype Analysis

Having access to credible news sources related to Bluebird Bio's direct competition is more important than ever and may enhance your ability to predict Bluebird Bio's future price movements. Getting to know how Bluebird Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bluebird Bio may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
MRSNMersana Therapeutics 0.18 8 per month 4.75  0.13  12.03 (9.72) 32.25 
ZNTLZentalis Pharmaceuticals Llc 0.16 8 per month 5.10  0.02  11.41 (8.20) 33.76 
YMABY mAbs Therapeutics 0.24 9 per month 0.00 (0.13) 5.00 (5.31) 22.06 
TVTXTravere Therapeutics(0.44)8 per month 2.10  0.13  6.98 (4.13) 19.78 
MDGLMadrigal Pharmaceuticals(14.71)10 per month 2.12  0.08  5.17 (3.62) 30.27 
VKTXViking Therapeutics(0.89)11 per month 0.00 (0.03) 6.24 (7.75) 34.61 
SRPTSarepta Therapeutics(3.77)8 per month 2.17 (0.04) 3.75 (3.33) 17.87 
HEPAHepion Pharmaceuticals(0.02)4 per month 0.00 (0.05) 8.06 (8.00) 33.54 
PTCTPTC Therapeutics(0.01)10 per month 2.10  0.16  7.02 (3.75) 23.95 
AGIOAgios Pharm(0.43)10 per month 4.58 (0.02) 5.24 (5.39) 31.56 
ICPTIntercept Pharmaceuticals 0.66 3 per month 0.00 (0.17) 5.23 (8.32) 38.17 
KPTIKaryopharm Therapeutics(0.05)9 per month 3.25  0  8.97 (5.56) 26.95 
CLVSQClovis Oncology 0.00 0 per month 0.00 (0.01) 33.33 (25.00) 121.43 
CVACCureVac NV(0.08)7 per month 2.47  0.01  5.19 (4.51) 16.27 
RETAReata Pharmaceuticals(0.50)3 per month 3.31  0.02  5.24 (3.51) 28.80 
KRYSKrystal Biotech(8.55)10 per month 2.15 (0.03) 4.45 (3.75) 12.22 
VIRVir Biotechnology 0.11 6 per month 4.16 (0.01) 5.50 (7.22) 35.87 
PPCBPropanc Biopharma 0.00 0 per month 0.00 (0.04) 33.33 (25.00) 58.33 

Bluebird Bio Additional Predictive Modules

Most predictive techniques to examine Bluebird price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bluebird using various technical indicators. When you analyze Bluebird charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Bluebird Bio Predictive Indicators

The successful prediction of Bluebird Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bluebird bio, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bluebird Bio based on analysis of Bluebird Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bluebird Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bluebird Bio's related companies.
 2021 2022 2023 2024 (projected)
Graham Number31.5913.818.778.33
Receivables Turnover0.320.332.272.15

Story Coverage note for Bluebird Bio

The number of cover stories for Bluebird Bio depends on current market conditions and Bluebird Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bluebird Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bluebird Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Bluebird Bio Short Properties

Bluebird Bio's future price predictability will typically decrease when Bluebird Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bluebird bio often depends not only on the future outlook of the potential Bluebird Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bluebird Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding192.8 M

Complementary Tools for Bluebird Stock analysis

When running Bluebird Bio's price analysis, check to measure Bluebird Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluebird Bio is operating at the current time. Most of Bluebird Bio's value examination focuses on studying past and present price action to predict the probability of Bluebird Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluebird Bio's price. Additionally, you may evaluate how the addition of Bluebird Bio to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Transaction History
View history of all your transactions and understand their impact on performance
CEOs Directory
Screen CEOs from public companies around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope